Nuvation Bio Inc.

NYSE: NUVB · Real-Time Price · USD
2.75
-0.01 (-0.36%)
At close: Aug 15, 2025, 3:59 PM
2.80
2.00%
After-hours: Aug 15, 2025, 07:39 PM EDT

Nuvation Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
4.83M 3.08M 5.71M 727K 1.44M n/a 264K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
2.58M 2.09M 4.22M 1.51M 1.59M n/a 55K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
2.26M 990K 1.5M -788K -156K -58K 209K -55K -38K n/a -106K -217K -114K -47K -43K -70K -41K -30K
Operating Income
-63.59M -59M -53.94M -48.1M -470.38M -20.2M -20.83M -26.34M -26.13M -26.52M -24.34M -29.34M -37.87M -28.19M -29.61M -22.79M -20.43M -20.48M
Interest Income
4.78M 5.32M 6.06M 6.73M 7.14M 7.13M 7.02M 6.52M 6.09M 4.98M 3.52M 2.13M 841K 958K 902K 847K 776K 438K
Pretax Income
-59.01M -53.24M -49.45M -41.21M -462.49M -14.79M -13.79M -19.65M -20.64M -21.73M -20.84M -27.2M -34.86M -21.29M -25.13M -21.98M -19.33M -20.4M
Net Income
-59.01M -53.24M -49.45M -41.21M -462.49M -14.79M -13.79M -19.65M -20.64M -21.73M -20.84M -27.2M -34.86M -21.29M -25.13M -21.98M -19.33M -20.4M
Selling & General & Admin
38.48M 35.39M 26.14M 19.58M 16.16M 7.3M 5.42M 7.78M 7.54M 7.73M 7.46M 8.04M 8.95M 7.46M 7.61M 5.67M 6.4M 4.61M
Research & Development
27.36M 24.6M 29.3M 27.73M 29.25M 12.84M 15.35M 18.56M 18.59M 18.79M 16.87M 21.29M 28.92M 20.73M 22M 17.12M 14.03M 15.88M
Other Expenses
n/a n/a n/a n/a -247K n/a n/a -228K -231K n/a -225K -263K -215K -169K -190K -170K -176K -108K
Operating Expenses
65.85M 59.99M 55.22M 47.31M 45.16M 20.14M 20.78M 26.34M 26.13M 26.52M 24.34M 29.34M 37.87M 28.19M 29.61M 22.79M 20.43M 20.48M
Interest Expense
421K 54K 89K 120K 132K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a -198K n/a 500K -58K -55K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
68.42M 62.09M 59.65M 48.83M 46.75M 20.2M 20.83M 26.34M 26.13M 26.52M 24.34M 29.34M 37.87M 28.19M 29.61M 22.79M 20.43M 20.48M
Income Tax Expense
n/a n/a n/a n/a n/a 14.72K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
340.75M 338.61M 336.93M 273.56M 244.74M 219.05M 218.99M 218.94M 218.85M 218.74M 218.5M 218.3M 216.6M 213.41M 210.36M 207.1M 204.02M 169.66M
Shares Outstanding (Diluted)
340.75M 338.61M 336.93M 273.56M 244.74M 219.05M 218.99M 218.94M 218.85M 218.74M 218.5M 218.3M 216.6M 213.41M 210.36M 207.1M 204.02M 169.66M
EPS (Basic)
-0.17 -0.16 -0.15 -0.15 -1.89 -0.07 -0.06 -0.09 -0.09 -0.1 -0.1 -0.12 -0.16 -0.1 -0.12 -0.11 -0.09 -0.12
EPS (Diluted)
-0.17 -0.16 -0.15 -0.15 -1.89 -0.07 -0.06 -0.09 -0.09 -0.1 -0.1 -0.12 -0.16 -0.1 -0.11 -0.11 -0.09 -0.12
EBITDA
-58.59M -59M -49.14M -41.09M -462.12M -20.14M -20.78M -19.59M -20.6M -26.46M -24.29M -29.28M -37.82M -28.15M -29.57M -22.72M -20.39M -20.45M
EBIT
-58.59M -59M -49.36M -41.09M -462.36M -20.2M -20.83M -19.65M -20.64M -26.52M -24.34M -29.34M -37.87M -28.19M -29.61M -22.79M -20.43M -20.48M
Depreciation & Amortization
n/a 310K 219K 162K 244K 58K 55K 55K 38K 56K 106K 217K 114K 47K 43K 70K 41K 30K